Abstract:Cancer, a leading cause of death worldwide, still needs surgery as essential curation in over 80% population. However, complete resection of cancerous tissues remains a great challenge due to the difficulty in tumor margin identification. Fluorescent probe based imaged-guided surgery (IGS) for in-situ local disease focus imaging is thought to be an ideal method for intraoperation tumor identification due to its high spatiotemporal resolution and real-time manner. By targeting tumor microenvironments (TME) or tumor-associated biomolecules, fluorescent probes could "light-up" tumor tissues and navigate surgical operation. Among which, biosensors targeting aminopeptidase N (APN) have attracted intense attention due to its high relevance with progression of tumor. However, most of the probes adopting its natural substrate (L-Alaine) as the recognition unit may be vulnerable toward other widely distributed aminopeptidase such as leukotriene A 4 hydrolase (LTA 4 H) and leucine aminopeptidase (LAP). In order to acquire high specific APN targeted probe for accurate detection of APN activity in biological samples and fulfill high contrast tumor imaging, herein a non-natural amino acid (P-Chloro-L-Phenylalanine, PCPA) based fluorescent probe was firstly reported for APN targeted bioimaging. The acquired named as TMN-PCPA showed high affinity ( K m = 3.27 ± 0.23 μM) and dramatically improved selectivity toward APN than previously reported APN probe. TMN-PCPA was successfully applicated into discrimination tumor bio-samples from normal bio-samples in both cellular and ex vivo level with significantly increased tumor to normal (T/N) ratio, thus showed great potential in intraoperation application such imaged-guided surgery and providing structural basis to high specific APN targeted biosensor construction.

Biocompatible Ratiometric Fluorescent Chemosensor for Ultrasensitive Detection of Endogenous Aminopeptidase N in Vitro and in Vivo

Ultrasensitive Detection of Aminopeptidase N Activity in Urine and Cells with a Ratiometric Fluorescence Probe

A novel aminopeptidase N triggered near-infrared fluorescence probe for imaging enzyme activity in cells and mice

Development of a novel latent electrochemical molecular substrate for the real-time monitoring of the tumor marker aminopeptidase N in live cells, whole blood and urine

A Facile Turn-on Chemiluminescence Probe for Sensitive Imaging on Aminopeptidase N Activity.

A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis

An Aminopeptidase N-based Color-Convertible Fluorescent Nano-Probe for Cancer Diagnosis

The first ratiometric fluorescent probes for aminopeptidase N cell imaging.

In situ imaging of aminopeptidase N activity in hepatocellular carcinoma: a migration model for tumour using an activatable two-photon NIR fluorescent probe

Cell-Membrane-Localizing Fluorescence Probes for Aminopeptidase N

The first ratiometric fluorescent probe for aminopeptidase N

Precipitated Fluorophore-Based Molecular Probe For In Situ Imaging Of Aminopeptidase N In Living Cells And Tumors

High-contrast tumor imaging via a de novo designed aminopeptidase N targeted fluorogenic probe

Novel ratiometric fluorescent probe for real-time detection of alkaline phosphatase and its application in living cells

A Bestatin-Based Fluorescent Probe for Aminopeptidase N Cell Imaging

A novel low-cytotoxicity fluorescent probe applied to monitor pH in vivo and in vitro

In Situ imaging of orthotopic kidney cancer in the murine model using an aminopeptidase N activatable fluorescent probe

A NIR fluorescent probe for the detection of renal damage based on overrepresentation of alanine aminopeptidase enzyme

Aminopeptidase N Activatable Fluorescent Probe for Tracking Metastatic Cancer and Image-Guided Surgery via in Situ Spraying

Aminopeptidase‐N‐activated Theranostic Prodrug for NIR Tracking of Local Tumor Chemotherapy

A Ratiometric Fluorescent Probe For In Vivo Tracking Of Alkaline Phosphatase Level Variation Resulting From Drug-Induced Organ Damage